U.S. patent number D943,733 [Application Number D/737,702] was granted by the patent office on 2022-02-15 for evaluation unit for inhalers.
This patent grant is currently assigned to APTAR RADOLFZELL GMBH. The grantee listed for this patent is Aptar Radolfzell GmbH. Invention is credited to Matthieu Cavatorta, Line Huchet, Matthieu Walter.
United States Patent |
D943,733 |
Cavatorta , et al. |
February 15, 2022 |
Evaluation unit for inhalers
Claims
CLAIM The ornamental design for an evaluation unit for inhalers, as
shown and described.
Inventors: |
Cavatorta; Matthieu
(Autouillet, FR), Huchet; Line (Saint-Germain en
Laye, FR), Walter; Matthieu (Villepreux,
FR) |
Applicant: |
Name |
City |
State |
Country |
Type |
Aptar Radolfzell GmbH |
Radolfzell |
N/A |
DE |
|
|
Assignee: |
APTAR RADOLFZELL GMBH
(Radolfzell, DE)
|
Appl.
No.: |
D/737,702 |
Filed: |
June 11, 2020 |
Foreign Application Priority Data
|
|
|
|
|
Apr 30, 2020 [EM] |
|
|
007849666 |
|
Current U.S.
Class: |
D24/110;
D24/110.5 |
Current International
Class: |
2402 |
Field of
Search: |
;D24/107,108,110,110.1-110.5,127,164,190,113 ;D9/448 ;D28/7 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
007849666-0001 |
|
Apr 2020 |
|
EM |
|
9007849666-0001 |
|
Apr 2020 |
|
GB |
|
Other References
Orbital.RTM. Dry Powder Inhaler, pharmaxis/ Aptar Radolfzell GmbH,
[Postdate unknown], [Site seen Nov. 23, 2021], Seen at URL:
https://www.pharmaxis.com.au/product-pipeline/other-pipeline-assets/orbit-
al-dry-powder-inhaler/ (Year: 2021). cited by examiner .
U.S. Appl. No. 29/734,519, filed May 13, 2020. cited by
applicant.
|
Primary Examiner: Vujcic; Natasha
Assistant Examiner: Ford; Gilbert B
Attorney, Agent or Firm: Flynn Thiel, P.C.
Description
FIG. 1 is a perspective view of an evaluation unit for inhalers
showing our new design;
FIG. 2 is a front view thereof;
FIG. 3 is a right side view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a top view thereof; and,
FIG. 7 is a bottom view thereof.
The broken lines in the drawings illustrate portions of the
evaluation unit for inhalers and form no part of the claimed
design.
* * * * *
References